The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development
Open accessAbstract
Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic, inflammatory disorder that affects synovial joints, both small and large joints, in a symmetric pattern. This disorder usually does not directly cause death but significantly reduces the quality of life and life expectancy of patients if left untreated. There is no cure for RA but, patients are usually on long-term disease modifying anti-rheumatic drugs (DMARDs) to suppress the joint inflammation, to minimize joint damage, to preserve joint function, and to keep the disease in remission. RA is strongly associated with various immune cells and each of the cell type contributes differently to the disease pathogenesis. Several types of immunomodulatory molecules mainly cytokines secreted from immune cells mediate pathogenesis of RA, hence complicating the disease treatment and management. There are various treatments for RA depending on the severity of the disease and more importantly, the patient’s response towards the given drugs. Early diagnosis of RA and treatment with (DMARDs) are known to significantly improve the treatment outcome of patients. Sensitive biomarkers are crucial in early detection of disease as well as to monitor the disease activity and progress. This review aims to discuss the pathogenic role of various immune cells and immunological molecules in RA. This review also highlights the importance of understanding the immune cells in treating RA and in exploring novel biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Suurmond, J., Dorjée, A. L., Boon, M. R., Knol, E. F., Huizinga, T. W. J., Toes, R. E. M., & Schuerwegh, A. J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3466 · Cited by 84
RetractedROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018) · Bone Research · doi:10.1038/s41413-018-0016-9 · Cited by 1,767
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
Matrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis
Rao, D. A., Gurish, M. F., Marshall, J. L., Slowikowski, K., Fonseka, C. Y., Liu, Y., Donlin, L. T., Henderson, L. A., Wei, K., Mizoguchi, F., et al. (2017) · Nature · doi:10.1038/nature20810 · Cited by 1,125
Effector and Memory CTL Differentiation
Williams, M. A., & Bevan, M. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141548 · Cited by 949
Mackay, F., & Schneider, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2572 · Cited by 930
Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.
Choy, E. (2012) · Rheumatology · doi:10.1093/rheumatology/kes113 · Cited by 816
Macrophages in rheumatoid arthritis.
Kinne, R. W., Bräuer, R., Stuhlmüller, B., Palombo‐Kinne, E., & Burmester, G. R. (2000) · Arthritis Research · doi:10.1186/ar86 · Cited by 772
Anderson, J., Caplan, L., Yazdany, J., Robbins, M. L., Neogi, T., Michaud, K., Saag, K. G., O'dell, J. R., & Kazi, S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21649 · Cited by 748
RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., & Higashio, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9788 · Cited by 746
Dixon, W. G., Hyrich, K. L., Watson, K. D., Lunt, M., Galloway, J., Ustianowski, A., & Symmons, D. P. M. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.118935 · Cited by 715
Cohen, S. B., Dore, R. K., Lane, N. E., Ory, P. A., Peterfy, C. G., Sharp, J. T., van der Heijde, D., Zhou, L., Tsuji, W., Newmark, R., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23417 · Cited by 576
Bondeson, J., Wainwright, S. D., Lauder, S., Amos, N., & Hughes, C. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2099 · Cited by 527
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Vossenaar, E. R., Després, N., Lapointe, E., van der Heijden, A., Lora, M., Senshu, T., van Venrooij, W. J., & Ménard, H. A. (2004) · Arthritis Res Ther · doi:10.1186/ar1149 · Cited by 463
Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis
Mateen, S., Zafar, A., Moin, S., Khan, A. Q., & Zubair, S. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.010 · Cited by 418
Benham, H., Nel, H. J., Law, S. C., Mehdi, A. M., Street, S., Ramnoruth, N., Pahau, H., Lee, B. T., Ng, J., G. Brunck, M. E., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9301 · Cited by 379
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value.
van Boekel, M. A. M., Vossenaar, E. R., van den Hoogen, F. H. J., & VENROOIJ, W. J. V. (2002) · Arthritis Research · doi:10.1186/ar395 · Cited by 359
Impaired early B cell tolerance in patients with rheumatoid arthritis
Samuels, J., Ng, Y.-S., Coupillaud, C., Paget, D., & Meffre, E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042321 · Cited by 328
The role of autoantibodies in the pathophysiology of rheumatoid arthritis
Derksen, V. F. A. M., Huizinga, T. W. J., & van der Woude, D. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0627-z · Cited by 327
The central role of T cells in rheumatoid arthritis.
Cope, A. P., Schulze‐Koops, H., & Aringer, M. (2007) · PubMed · Cited by 300
Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy
Alam, J., Jantan, I., & Bukhari, S. N. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.055 · Cited by 280
The balance of Th1/Th2 cytokines in rheumatoid arthritis
Schulze-Koops, H., & Kalden, J. R. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0187 · Cited by 275
Antirheumatic Drugs and the Risk of Tuberculosis
Brassard, P., Kezouh, A., & Suissa, S. (2006) · Clinical Infectious Diseases · doi:10.1086/506935 · Cited by 266
Anti–citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis
Aggarwal, R., Liao, K., Nair, R., Ringold, S., & Costenbander, K. H. (2009) · Arthritis Care & Research · doi:10.1002/art.24827 · Cited by 253
Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair
Paiva, K. B. S., & Granjeiro, J. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.05.001 · Cited by 236
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
Gaffen, S. L. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0052-y · Cited by 235
Cytokines as Biomarkers in Rheumatoid Arthritis
Burska, A., Boissinot, M., & Ponchel, F. (2014) · Mediators of Inflammation · doi:10.1155/2014/545493 · Cited by 222
Targeting monocytes/macrophages in the treatment of rheumatoid arthritis
Davignon, J.-L., Hayder, M., Baron, M., Boyer, J.-F., Constantin, A., Apparailly, F., Poupot, R., & Cantagrel, A. (2013) · Rheumatology · doi:10.1093/rheumatology/kes304 · Cited by 209
Brzustewicz, E., & Bryl, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.08.260 · Cited by 196
Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies
Song, Y. W., & Kang, E. H. (2010) · QJM · doi:10.1093/qjmed/hcp165 · Cited by 190
Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
Centola, M., Cavet, G., Shen, Y., Ramanujan, S., Knowlton, N., Swan, K. A., Turner, M., Sutton, C., Smith, D. R., Haney, D. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060635 · Cited by 186
Meednu, N., Zhang, H., Owen, T., Sun, W., Wang, V., Cistrone, C., Rangel‐Moreno, J., Xing, L., & Anolik, J. H. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39489 · Cited by 182
T cells in rheumatoid arthritis
Cope, A. P. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2412 · Cited by 177
Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.
Kim, S.-S., Ye, C., Kumar, P., Chiu, I., Subramanya, S., Wu, H., Shankar, P., & Manjunath, N. (2010) · Molecular Therapy · doi:10.1038/mt.2010.27 · Cited by 176
Rituximab for the treatment of rheumatoid arthritis: an update
Mok, C. C. (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s41645 · Cited by 176
B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
Bugatti, S., Vitolo, B., Caporali, R., Montecucco, C., & Manzo, A. (2014) · BioMed Research International · doi:10.1155/2014/681678 · Cited by 170
T Cells That Help B Cells in Chronically Inflamed Tissues
Rao, D. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01924 · Cited by 169
Takeuchi, T., Tanaka, Y., Ishiguro, N., Yamanaka, H., Yoneda, T., Ohira, T., Okubo, N., Genant, H. K., & van der Heijde, D. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208052 · Cited by 168
Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
Hilkens, C. M. U., & Isaacs, J. D. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12038 · Cited by 158
Regulation of B‐cell responses by Toll‐like receptors
Browne, E. P. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03587.x · Cited by 156
Meffre, E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06347.x · Cited by 155
Choi, I. Y. K., Gerlag, D. M., Herenius, M. M. J., Thurlings, R. M., Wijbrandts, C. A., Foell, D., Vogl, T., Roth, J., Tak, P. P., & Holzinger, D. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203923 · Cited by 154
Podojil, J. R., & Miller, S. D. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00773.x · Cited by 144
Nandakumar, K. S., & Holmdahl, R. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.06.017 · Cited by 134
Alunno, A., Manetti, M., Caterbi, S., Ibba‐Manneschi, L., Bistoni, O., Bartoloni, E., Valentini, V., Terenzi, R., & Gerli, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/751793 · Cited by 133
Dendritic cells as targets for therapy in rheumatoid arthritis
Khan, S. A., Greenberg, J. D., & Bhardwaj, N. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.185 · Cited by 130
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
Shaw, T., Quan, J., & Totoritis, M. C. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii55 · Cited by 126
The vasculature in rheumatoid arthritis: cause or consequence?
Paleolog, E. M. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00640.x · Cited by 125
Regulatory T cells (Treg) in rheumatoid arthritis
Boissier, M., Assier, É., Biton, J., Denys, A., Falgarone, G., & Bessis, N. (2008) · Joint Bone Spine · doi:10.1016/j.jbspin.2008.08.002 · Cited by 123
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis
Ciccia, F., Guggino, G., Rizzo, A., et al. (2015) · Lara D. Veeken · doi:10.1093/rheumatology/kev252 · Cited by 112
Treg Cells in Rheumatoid Arthritis: An Update
Cooles, F. A. H., Isaacs, J. D., & Anderson, A. E. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0352-0 · Cited by 109
Heo, R., Park, J. S., Jang, H. J., Kim, S.-H., Shin, J. M., Suh, Y. D., Jeong, J. H., Jo, D., & Park, J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.057 · Cited by 103
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
Morita, T., Shima, Y., Wing, J. B., Sakaguchi, S., Ogata, A., & Kumanogoh, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162306 · Cited by 98
Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors
Mewar, D., & Wilson, A. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01099.x · Cited by 97
Maksymowych, W. P., Naides, S. J., Bykerk, V., Siminovitch, K. A., van Schaardenburg, D., Boers, M., Landewé, R., van der Heijde, D. M. F. M., Tak, P.-P., Genovese, M. C., et al. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.131446 · Cited by 97
Luime, J. J., Colin, E. M., Hazes, J. M. W., & Lubberts, E. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.103283 · Cited by 90
B-cell selection and the development of autoantibodies
Giltiay, N. V., Chappell, C. P., & Clark, E. A. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3918 · Cited by 88
El‐Saadany, H. M., Hussein, M. S., Gaber, R. A., & Zaytoun, H. A. (2015) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2015.01.001 · Cited by 84
Bone Remodelling Markers in Rheumatoid Arthritis
Fardellone, P., Séjourné, A., Paccou, J., & Goëb, V. (2014) · Mediators of Inflammation · doi:10.1155/2014/484280 · Cited by 82
Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis
Chiu, Y. G., & Ritchlin, C. T. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1263614 · Cited by 82
The function of myeloid dendritic cells in rheumatoid arthritis
Yu, M. B., & Langridge, W. H. R. (2017) · Rheumatology International · doi:10.1007/s00296-017-3671-z · Cited by 75
Boyce, E. G., Rogan, E. L., Vyas, D., Prasad, N., & Mai, Y. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018761599 · Cited by 75
Chowdhury, K., Kumar, U., Das, S., Chaudhuri, J., Kumar, P., Kanjilal, M., Ghosh, P., Sircar, G., Basyal, R. K., Kanga, U., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1505-8 · Cited by 72
Dzhambazov, B. M., Nandakumar, K. S., Kihlberg, J. O., Fugger, L. H., Holmdahl, R., & Vestberg, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1525 · Cited by 70
Molfino, N. A., Kuna, P., Leff, J. A., Oh, C. K., Singh, D., Chernow, M., Sutton, B., & Yarranton, G. T. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-007709 · Cited by 66
Mast cells in rheumatoid arthritis: friends or foes?
Rivellese, F., Nerviani, A., Rossi, F. W., Marone, G., Matucci‐Cerinic, M., de Paulis, A., & Pitzalis, C. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.04.001 · Cited by 64
Aarvak, T., & Natvig, J. B. (2001) · Arthritis Research · doi:10.1186/ar135 · Cited by 62
Yee, A., Webb, T. T., Seaman, A., Infantino, M. G., Meacci, F., Manfredi, M., Benucci, M., Lakos, G., Favalli, E. G., Schioppo, T., et al. (2014) · Immunologic Research · doi:10.1007/s12026-014-8560-x · Cited by 62
B cell depletion in autoimmune disease.
Gorman, C., Leandro, M. J., & Isenberg, D. A. (2003) · Arthritis Research · doi:10.1186/ar1007 · Cited by 57
Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis
Taylor, P. C. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454991 · Cited by 57
Natural Killer Cells and Their Role in Rheumatoid Arthritis: Friend or Foe?
Shegarfi, H., Naddafi, F., & Mirshafiey, A. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/491974 · Cited by 57
Inflammation‐independent defective early B cell tolerance checkpoints in rheumatoid arthritis
Menard, L. C., Samuels, J., Ng, Y.-S., & Meffre, E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30164 · Cited by 55
Morozzi, G., Fabbroni, M., Bellisai, F., Cucini, S., Simpatico, A., & Galeazzi, M. (2007) · Clinical Rheumatology · doi:10.1007/s10067-006-0520-y · Cited by 53
Schlegel, P. M., Steiert, I., Kötter, I., & Müller, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082580 · Cited by 48
Mease, P. J. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq285 · Cited by 40
Rapetti, L., Chavele, K.-M., Evans, C. M., & Ehrenstein, M. R. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204049 · Cited by 39
Isgren, A., Forslind, K., Erlandsson, M. C., Axelsson, C., Andersson, S. E. M., Lund, A., & Bokarewa, M. I. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.08.005 · Cited by 39
Golimumab for Rheumatoid Arthritis: A Systematic Review
Singh, J. A., Noorbaloochi, S., & Singh, G. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091466 · Cited by 38
Active immunization against IL-23p19 improves experimental arthritis
Ratsimandresy, R. A., Duvallet, E., Assier, É., Semerano, L., Delavallée, L., Bessis, N., Zagury, J., & Boissier, M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.134 · Cited by 38
Zimmerman, D. H., Taylor, P., Bendele, A. M., Carambula, R. E., Duzant, Y., Lowe, V., O’Neill, S. P., Talor, E., & Rosenthal, K. S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.016 · Cited by 37
Smolen, J. S., Weinblatt, M. E., van der Heijde, D. M. F. M., Rigby, W. F. C., van Vollenhoven, R., Bingham, C. O., Veenhuizen, M. F., Gill, A. M., Zhao, F., Komocsar, W. J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207090 · Cited by 36
Huizinga, T. W. J., Batalov, A. Z., Stoilov, R. M., Lloyd, E., Wagner, T., Saurigny, D., Souberbielle, B. E., & Esfandiari, E. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1267-3 · Cited by 35
Cook, A. D., & Hamilton, J. A. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x17752036 · Cited by 35
Rosenthal, K. S., Mikecz, K., Steiner, H. L., Glant, T. T., Finnegan, A., Carambula, R. E., & Zimmerman, D. H. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1026330 · Cited by 33
Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis
Langdon, K., & Haleagrahara, N. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2018.1465943 · Cited by 30
Fabris, M., Vita, S. D., Blasone, N., Visentini, D., Pezzarini, E., Pontarini, E., Fabro, C., Quartuccio, L., Mazzolini, S., Curcio, F., et al. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0013-5 · Cited by 29
Lorenzo, P., Aspberg, A., Saxne, T., & Önnerfjord, P. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.04.004 · Cited by 28
Niki, Y., Takeuchi, T., Nakayama, M., Nagasawa, H., Kurasawa, T., Yamada, H., Toyama, Y., & Miyamoto, T. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037447 · Cited by 27
Developments with investigational Janus kinase inhibitors for rheumatoid arthritis
Semerano, L., Decker, P., Clavel, G., & Boissier, M. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1249565 · Cited by 25
Interleukin 6 receptor as a target for the treatment of rheumatoid arthritis
Choy, E. H. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii68 · Cited by 21
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
Crotti, C., Raimondo, M. G., Becciolini, A., Biggioggero, M., & Favalli, E. G. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s104233 · Cited by 19
Autoantibodies Associated with Rheumatic Diseases
Griesmacher, A., & Peichl, P. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.031 · Cited by 18
Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib
Ni, H., Moe, S., Myint, K. T., & Htet, A. (2013) · ISRN Rheumatology · doi:10.1155/2013/357904 · Cited by 14
Darweesh, H., Abbass, D., Kadah, R., Rashad, A., Basel, M. E., & Nasr, A. S. (2010) · Indian Journal of Rheumatology · doi:10.1016/s0973-3698(10)60556-0 · Cited by 10
Kivitz, A. J., Hazan, L., Hoffman, K., & Wallin, B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-eular.3186 · Cited by 10
Marotta, A., & Maksymowych, W. P. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-eular.3426 · Cited by 9
Vaccine development for rheumatoid arthritis
Malemud, C. J. (2015) · Global Vaccines and Immunology · doi:10.15761/gvi.1000102 · Cited by 5
Cited by
Management of Rheumatoid Arthritis: An Overview
Radu, A.-F., & Bungau, S. G. (2021) · Cells · doi:10.3390/cells10112857 · Cited by 1,089
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
Mueller, A.-L., Payandeh, Z., Mohammadkhani, N., Mubarak, S. M. H., Zakeri, A., Alagheband Bahrami, A., Brockmueller, A., & Shakibaei, M. (2021) · Cells · doi:10.3390/cells10113017 · Cited by 256
Li, W., Wang, K., Liu, Y., Wu, H., He, Y., Li, C., Wang, Q., Su, X., Yan, S., Su, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912933 · Cited by 106
study, T. A. I. B. A. L., Nabais, M. F., Initiative, T. A. D. N., Laws, S. M., Lin, T., Vallerga, C. L., Armstrong, N. J., Blair, I. P., Kwok, J. B., Mather, K. A., et al. (2021) · Genome Biology · doi:10.1186/s13059-021-02275-5 · Cited by 99
Metadata
- Authors
- Yap, H.-Y., Tee, S. Z.-Y., Wong, M. M.-T., Chow, S.-K., Peh, S.-C., & Teow, S.-Y.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2018-10-09
- Volume
- 7
- Issue
- 10
- Pages
- 161
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2896285785
- Cited by
- 486
- References
- 100
- FWCI
- 24.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.